Skip to content
stockresearch.app
DGX/History

Quest Diagnostics (DGX) valuation history

Historically high

As of

DGX's EV/EBITDA of 14.4x is higher than 98% of its available weekly readings from the last five years.

EV/EBITDA weekly history5.4×9×12.6×16.3×Shading: 5-year middle halfMedian 12.0×14.4×202120232025
Share EV/EBITDA history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/EBITDA at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

DGX year-end valuation history
Reading dateEV/EBITDA5-year rank
11.9×63%
13.2×91%
12.6×83%
9.6×38%
8.1×14%
10.2×9%
12.7×78%
10.3×13%
12.0×73%
11.0×Short history

Loading related research…

About this history

What is DGX's current EV/EBITDA?
DGX's EV/EBITDA of 14.4x is higher than 98% of its available weekly readings from the last five years.
What is DGX's five-year median EV/EBITDA?
The median, or middle weekly reading, is 12.0× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology